WALID ELZOMOR: Open Payments
NPI 1255374930 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 22 payments from 7 companies in 2025. Trend: 2023 $1,748 · 2024 $1,475 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 8 | $380 |
| Edwards Lifesciences Corporation | 4 | $173 |
| Madrigal Pharmaceuticals | 1 | $150 |
| AtriCure, Inc. | 3 | $85 |
| Getinge USA Sales, LLC | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| Solventum Corporation | 1 | $23 |
Products named: REZDIFFRA, MITRIS RESILIA Mitral Valve, VASOVIEW HEMOPRO 2, SYNERGY ABLATION SYSTEM, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, LEQVIO, PREVENA, KONECT RESILIA.
Industry payments across NY — which companies pay providers there.
